The U.S. Department of Transportation published a final rule April 23 that makes technical corrections to regulations governing drug testing for safety-sensitive employees to ensure consistency with recent amendments made to DOT’s “Procedures for Transportation Workplace Drug and Alcohol Testing Programs,” which recently added requirements for testing for oxycodone, oxymorphone, hydrocodone and hydromorphone.
According to the release from DOT, the new changes to the department’s regulations make it necessary to refer to these substances, as well as morphine, 6-acetylmorphine and codeine by the term “opioids” rather than “opiates.”
This final rule amends the term in the FAA, FTA and PHMSA regulations to ensure that all DOT drug testing rules are consistent with one another and the mandatory guidelines for the testing program.
Click here to read more about this final rule.
Related News
- Federal Protection for Train Crews Promised by Passenger Rail Crew Protection Act
- New Rail Safety Bill Addresses East Palestine “Vent and Burn” Failures
- Philadelphia Bus Operator Reinstated by Arbitration Victory
- Are You Registered to Vote? Check Your Status Today!
- CSX ENDS OPERATION REDBLOCK
- Registration Open for St. Paul Regional Training Seminar
- Important DOT Drug Testing Notice Affects Members
- Honoring the Life of Brother Ed Weathers, Jr.
- Members Helped Raise $200K for Brothers and Sisters in Need
- Resolve to Keep Your Timebook Current in 2026